Abstract:Background & Aims Disturbed hepatic metabolism frequently results in excessive lipid accumulation in the adipose tissue. However, the specific role of the liver–adipose axis in maintaining lipid homeostasis as well as the underlying mechanism has not yet been fully elucidated. In this study, we investigated the role of hepatic glucuronyl C5-epimerase ( Glce ) in the progression of obesity. Methods We determined the association between the expression of hepatic Glce and body mass index (BMI) in obese patients. Obesity models were established in hepatic Glce -knockout and wild-type mice fed a high-fat diet (HFD) to understand the effect of Glce on obesity development. The role of Glce in the progression of disrupted hepatokine secretion was examined via secretome analysis. Results Hepatic Glce expression was inversely correlated with BMI in obese patients. Moreover, Glce level was found to be decreased in the liver of HFD murine model. Hepatic Glce deficiency led to impaired thermogenesis in adipose tissue and exacerbated HFD-induced obesity. Interestingly, decreased level of growth differentiation factor 15 (GDF15) was observed in the culture medium of Glce -knockout mouse hepatocytes. Treatment with recombinant GDF15 obstructed obesity progression derived from the absence of hepatic Glce , similar to the effect of Glce or its inactive mutant overexpressed both in vitro and in vivo . Furthermore, liver Glce deficiency led to diminished production and increased degradation of mature GDF15, resulting in reduced hepatic GDF15 secretion. Conclusions Hepatic Glce deficiency facilitated obesity development, and decreased Glce expression further reduced hepatic secretion of GDF15, thereby perturbing lipid homeostasis in vivo . Therefore, the novel Glce –GDF15 axis plays an important role in maintaining energy balance and may act as a potential target for combating obesity. Impact and implications Evidence suggests that GDF15 plays a key role in hepatic metabolism; however, the molecular mechanism for regulating its expression and secretion is largely unknown. Our work observes that hepatic Glce , as a key Golgi-localized epimerase, may work on the maturation and post-translational regulation of GDF15. Hepatic Glce deficiency reduces the production of mature GDF15 protein and facilitates its ubiquitination, co-resulting in the aggravation of obesity development. This study may shed light on the new function and mechanism of Glce -GDF15 axis in lipid metabolism and provide a potential therapeutic target against obesity.

GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders

Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

GDF15 promotes weight loss by enhancing energy expenditure in muscle

GDF15 deficiency promotes high fat diet-induced obesity in mice

GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism

GDF15 is dispensable for the insulin-sensitizing effects of chronic exercise

Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH

Adaptive thermogenesis is mediated by GDF15 via the GFRAL neuronal axis in mice

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates

Growth/differentiation Factor 3 Signals Through ALK7 and Regulates Accumulation of Adipose Tissue and Diet-Induced Obesity

GDF15 is required for cold-induced thermogenesis and contributes to improved systemic metabolic health following loss of OPA1 in brown adipocytes

GDF5 Promotes White Adipose Tissue Thermogenesis Via P38 MAPK Signaling Pathway

Hepatic glucuronyl C5-epimerase combats obesity by stabilizing GDF15

GDF15 is a Major Determinant of Ketogenic Diet-Induced Weight Loss.

Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure

GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance

Saturated Fatty Acids Promote GDF15 Expression in Human Macrophages through the PERK/eIF2/CHOP Signaling Pathway